NEW YORK (GenomeWeb) – Sygnis said it has greatly expanded its Asian distribution network with a trio of deals with PhileKorea, Pharma Tech Korea, and Axil Scientific covering South Korea and Singapore.

Sygnis has granted non-exclusive rights to promote, market, and sell all existing and future product lines. PhileKorea and Pharma Tech Korea's deals cover the South Korean market; Axil Scientific's deal is for the Singaporean market.

Financial and other terms of the agreements were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.